Follow us:
  1. Home
  2. News
  3. High Blood Pressure

Macleods Pharmaceuticals recalls Losartan Potassium/Hydrochlorothiazide combination tablets

Trace amounts of an unexpected impurity were found in the product

Photo source: FDA
Macleods Pharmaceuticals Limited is recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets, a high blood pressure treatment.

Trace amounts of an unexpected impurity -- N-nitrosodiethylamine (NDEA) -- were detected found in the product. NDEA, which occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen by the International Agency for Research on Cancer.

There are no reports of adverse events related to this recall.

The following product, which is packaged in bottles, is being recalled:

  • NDC: 33342-0052-10
  • Manufacturer: Macleods Pharmaceuticals Limited
  • Product Description: Losartan Potassium/ Hydrochlorothiazide combination tablets 100mg/25mg, 90 count bottles
  • Lot/Batch: BLM715A
  • Expiration Date: Jul -2019

The recalled product was sold nationwide to Macleods wholesale distributor and retail customers.

What to do

Macleods Pharmaceuticals is notifying its customers by phone and/or in writing. Instructions for returning recalled products are given in the recall letter.

Consumers with questions regarding the return of the recalled product may contact Qualanex at (888) 280-2042 from 7:00 am to 4:00 pm (CST) Monday – Friday or by email at


Take a Quiz

Get matched with an Accredited Partner

Share your comments

Get the news you need delivered to you

Sign up to receive our free weekly newsletter. We value your privacy. Unsubscribe easily.

You’re signed up

We’ll start sending you the news you need delivered straight to you. We value your privacy. Unsubscribe easily.